Results for Respiratory Chain Disease

This week’s In the News highlights research on mitochondrial disease, acute lymphoblastic leukemia, type 2 diabetes, and sleep apnea.

CHOP and Penn researchers discussed the latest findings about the mechanisms of immunity at the CHOP Research Institute 2022 Scientific Symposium.

A combination of vitamins and supplements appears to be beneficial in treating mitochondrial disease, which has no approved treatment.

Study is first to demonstrate how specific combination therapy may be beneficial to patients with mitochondrial respiratory chain disorders.

Evaluating data from collaborating PEDSnet institutions yields epidemiological insight into SARS-CoV-2.

In this week’s roundup, learn about new findings in obesity and vitamin D, predicting early sepsis, and mitochondrial disorders.

New preclinical findings from extensive cell and animal studies suggest that a drug already used for a rare kidney disease could benefit patients with some mitochondrial disorders—complex conditions with severe energy deficiency for which no proven effective treatments exist. Future clinical research is needed to explore whether the drug, cysteamine bitartrate, will meaningfully benefit patients.

CHOP Study Highlights High Costs of These Disorders, Points to Urgent Need for Better Therapies

Let's say you want to buy a new television. You probably would do some digging and compare each brand's best features and consult reviews from other consumers before making a purchase. The decision-making process isn't always as straightforward, however, when you're faced with making a choice about your healthcare. Compelling information about the benefits and harms of a medical test,